BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T083000
DTEND;TZID=America/Vancouver:20211120T120000
DTSTAMP:20260407T113801
CREATED:20210920T030135Z
LAST-MODIFIED:20211115T175106Z
UID:18384-1637224200-1637409600@scienceinvancouver.com
SUMMARY:BC Cancer Summit
DESCRIPTION:Registration for the virtual 2021 BC Cancer Summit is now open! \nWe are delighted to host the BC Cancer Summit virtually this year from November 18 to 20. The Summit provides education\, professional development and relationship building opportunities for oncology professionals from all specialties and disciplines. \nThis year’s Summit will feature: \n\nKeynote presentation by the Right Honourable Beverley McLachlin\nKeynote on PRecision oncology Evidence Development in Cancer Treatment (PREDiCT) and Precision Oncology for Young People (PROFYLE)\nA selection of breakouts sessions\, a Terry Fox Research Institute (TFRI) BC Node Research Day\, and poster session\nCelebration of award recipients of the 2021 Terry Fox Medal and BC Cancer Excellence Awards\n\nClick here to register.\n\nWe look forward to having you join us at the Summit. Please register by 5 p.m.\, November 17.
URL:https://scienceinvancouver.com/event/bc-cancer-summit-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T083000
DTEND;TZID=America/Vancouver:20211120T120000
DTSTAMP:20260407T113801
CREATED:20210920T030135Z
LAST-MODIFIED:20210920T030135Z
UID:26438-1637224200-1637409600@scienceinvancouver.com
SUMMARY:BC Cancer Summit
DESCRIPTION:Registration for the virtual 2021 BC Cancer Summit is now open! \nWe are delighted to host the BC Cancer Summit virtually this year from November 18 to 20. The Summit provides education\, professional development and relationship building opportunities for oncology professionals from all specialties and disciplines. \nThis year’s Summit will feature: \n\nKeynote presentation by the Right Honourable Beverley McLachlin\nKeynote on PRecision oncology Evidence Development in Cancer Treatment (PREDiCT) and Precision Oncology for Young People (PROFYLE)\nA selection of breakouts sessions\, a Terry Fox Research Institute (TFRI) BC Node Research Day\, and poster session\nCelebration of award recipients of the 2021 Terry Fox Medal and BC Cancer Excellence Awards\n\nClick here to register.\n\nWe look forward to having you join us at the Summit. Please register by 5 p.m.\, November 17.
URL:https://scienceinvancouver.com/event/bc-cancer-summit-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T083000
DTEND;TZID=America/Vancouver:20211120T120000
DTSTAMP:20260407T113801
CREATED:20210920T030135Z
LAST-MODIFIED:20210920T030135Z
UID:28053-1637224200-1637409600@scienceinvancouver.com
SUMMARY:BC Cancer Summit
DESCRIPTION:Registration for the virtual 2021 BC Cancer Summit is now open! \nWe are delighted to host the BC Cancer Summit virtually this year from November 18 to 20. The Summit provides education\, professional development and relationship building opportunities for oncology professionals from all specialties and disciplines. \nThis year’s Summit will feature: \n\nKeynote presentation by the Right Honourable Beverley McLachlin\nKeynote on PRecision oncology Evidence Development in Cancer Treatment (PREDiCT) and Precision Oncology for Young People (PROFYLE)\nA selection of breakouts sessions\, a Terry Fox Research Institute (TFRI) BC Node Research Day\, and poster session\nCelebration of award recipients of the 2021 Terry Fox Medal and BC Cancer Excellence Awards\n\nClick here to register.\n\nWe look forward to having you join us at the Summit. Please register by 5 p.m.\, November 17.
URL:https://scienceinvancouver.com/event/bc-cancer-summit-2-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T083000
DTEND;TZID=America/Vancouver:20211120T120000
DTSTAMP:20260407T113801
CREATED:20210920T030135Z
LAST-MODIFIED:20210920T030135Z
UID:31136-1637224200-1637409600@scienceinvancouver.com
SUMMARY:BC Cancer Summit
DESCRIPTION:Registration for the virtual 2021 BC Cancer Summit is now open! \nWe are delighted to host the BC Cancer Summit virtually this year from November 18 to 20. The Summit provides education\, professional development and relationship building opportunities for oncology professionals from all specialties and disciplines. \nThis year’s Summit will feature: \n\nKeynote presentation by the Right Honourable Beverley McLachlin\nKeynote on PRecision oncology Evidence Development in Cancer Treatment (PREDiCT) and Precision Oncology for Young People (PROFYLE)\nA selection of breakouts sessions\, a Terry Fox Research Institute (TFRI) BC Node Research Day\, and poster session\nCelebration of award recipients of the 2021 Terry Fox Medal and BC Cancer Excellence Awards\n\nClick here to register.\n\nWe look forward to having you join us at the Summit. Please register by 5 p.m.\, November 17.
URL:https://scienceinvancouver.com/event/bc-cancer-summit-2-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T083000
DTEND;TZID=America/Vancouver:20211120T120000
DTSTAMP:20260407T113801
CREATED:20210920T030135Z
LAST-MODIFIED:20210920T030135Z
UID:32596-1637224200-1637409600@scienceinvancouver.com
SUMMARY:BC Cancer Summit
DESCRIPTION:Registration for the virtual 2021 BC Cancer Summit is now open! \nWe are delighted to host the BC Cancer Summit virtually this year from November 18 to 20. The Summit provides education\, professional development and relationship building opportunities for oncology professionals from all specialties and disciplines. \nThis year’s Summit will feature: \n\nKeynote presentation by the Right Honourable Beverley McLachlin\nKeynote on PRecision oncology Evidence Development in Cancer Treatment (PREDiCT) and Precision Oncology for Young People (PROFYLE)\nA selection of breakouts sessions\, a Terry Fox Research Institute (TFRI) BC Node Research Day\, and poster session\nCelebration of award recipients of the 2021 Terry Fox Medal and BC Cancer Excellence Awards\n\nClick here to register.\n\nWe look forward to having you join us at the Summit. Please register by 5 p.m.\, November 17.
URL:https://scienceinvancouver.com/event/bc-cancer-summit-2-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T120000
DTEND;TZID=America/Vancouver:20211118T130000
DTSTAMP:20260407T113801
CREATED:20211111T005628Z
LAST-MODIFIED:20211111T005628Z
UID:19292-1637236800-1637240400@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Panel Discussion
DESCRIPTION:Have you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? This panel discussion event will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. Our speakers will discuss how investment banks identify promising scientific advances\, evaluate strategies\, and harness the power of capital to bring ideas to life. We will hear from life sciences graduates who have successfully made a transition into the world of investment banking and are now changing the face of biotech business in Canada. \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nObjectives \nIntroduce students and early career professionals to the roles investment banks and venture capital firms play for the biotechnology industry\nIdentify key qualifications for candidates interested in transitioning into the investment banking and venture capital industry careers\nProvide information on how a scientific project is evaluated based on the investment banking criteria \nSpeaker Information \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead.\nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University.\nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park. \nBharat Srinivasa\, PhD\nPrincipal\nAmplitude Ventures \nBharat Srinivasa is a co-founder and principal at Amplitude where he is involved in all aspects of deal flow including proving leadership in sourcing\, diligence\, and negotiation. Prior to Amplitude\, he was on the investment team at the BDC Healthcare Fund\, where he was involved in taking multiple companies public. Prior to his VC career\, Bharat was a consultant in forecasting and valuation practice at Foster Rosenblatt\, an international life science consulting firm for biotech and pharma companies where he was responsible for providing business intelligence and commercial analytics and pricing & market access analysis. Bharat has a PhD in Experimental Medicine and Masters of Science in Microbiology and Immunology from McGill University. \nSuman Rao\, PhD\nAssociate\nLumira Ventures \nSuman comes from a strong life science background\, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate and focuses on conducting scientific and technical diligence of investment opportunities. She remains extremely passionate about understanding drivers of complex diseases and through her work at Lumira Ventures\, hopes to bring novel therapies to patients by promoting cutting-edge technologies and medicines.\nPrior to joining Lumira Ventures\, Suman worked in healthcare consulting at L.E.K. Consulting in Boston as a Life Sciences Specialist. During her time at L.E.K.\, she provided strategic advice on growth opportunities\, pipeline expansion\, potential M&A partnerships and financial modeling. Before joining L.E.K.\, Suman spent 4 years doing a Postdoctoral Fellowship at Harvard Medical School and Dana Farber Cancer Institute. During this time\, she worked with a multidisciplinary team to develop therapies to treat advanced cancers. \nParas Sharma\, MSc\nAssociate\nGenesys Capital \nParas came to the Genesys team from adMare Bioinnovations\, where he was responsible for proactive identification of new opportunities\, deal sourcing\, financial valuations and company creation. Prior to his time at adMare\, he served as a Management Consultant providing primary strategic insights to big pharma\, and as a Venture Manager at the CDL.\nMr. Sharma has also held various scientific roles in early drug discovery group at Eisai Inc. and in clinical biomarker group at Alexion Pharma. He spent his early career in academic research at Abramson Cancer Center at UPenn.\nHe holds a Bachelor of Technology from Amity University\, a Master of Biotechnology from the University of Pennsylvania\, and an MBA from Sauder School of Business in University of British Columbia.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-panel-discussion/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Slide2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T120000
DTEND;TZID=America/Vancouver:20211118T130000
DTSTAMP:20260407T113801
CREATED:20211111T005628Z
LAST-MODIFIED:20211111T005628Z
UID:26466-1637236800-1637240400@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Panel Discussion
DESCRIPTION:Have you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? This panel discussion event will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. Our speakers will discuss how investment banks identify promising scientific advances\, evaluate strategies\, and harness the power of capital to bring ideas to life. We will hear from life sciences graduates who have successfully made a transition into the world of investment banking and are now changing the face of biotech business in Canada. \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nObjectives \nIntroduce students and early career professionals to the roles investment banks and venture capital firms play for the biotechnology industry\nIdentify key qualifications for candidates interested in transitioning into the investment banking and venture capital industry careers\nProvide information on how a scientific project is evaluated based on the investment banking criteria \nSpeaker Information \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead.\nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University.\nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park. \nBharat Srinivasa\, PhD\nPrincipal\nAmplitude Ventures \nBharat Srinivasa is a co-founder and principal at Amplitude where he is involved in all aspects of deal flow including proving leadership in sourcing\, diligence\, and negotiation. Prior to Amplitude\, he was on the investment team at the BDC Healthcare Fund\, where he was involved in taking multiple companies public. Prior to his VC career\, Bharat was a consultant in forecasting and valuation practice at Foster Rosenblatt\, an international life science consulting firm for biotech and pharma companies where he was responsible for providing business intelligence and commercial analytics and pricing & market access analysis. Bharat has a PhD in Experimental Medicine and Masters of Science in Microbiology and Immunology from McGill University. \nSuman Rao\, PhD\nAssociate\nLumira Ventures \nSuman comes from a strong life science background\, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate and focuses on conducting scientific and technical diligence of investment opportunities. She remains extremely passionate about understanding drivers of complex diseases and through her work at Lumira Ventures\, hopes to bring novel therapies to patients by promoting cutting-edge technologies and medicines.\nPrior to joining Lumira Ventures\, Suman worked in healthcare consulting at L.E.K. Consulting in Boston as a Life Sciences Specialist. During her time at L.E.K.\, she provided strategic advice on growth opportunities\, pipeline expansion\, potential M&A partnerships and financial modeling. Before joining L.E.K.\, Suman spent 4 years doing a Postdoctoral Fellowship at Harvard Medical School and Dana Farber Cancer Institute. During this time\, she worked with a multidisciplinary team to develop therapies to treat advanced cancers. \nParas Sharma\, MSc\nAssociate\nGenesys Capital \nParas came to the Genesys team from adMare Bioinnovations\, where he was responsible for proactive identification of new opportunities\, deal sourcing\, financial valuations and company creation. Prior to his time at adMare\, he served as a Management Consultant providing primary strategic insights to big pharma\, and as a Venture Manager at the CDL.\nMr. Sharma has also held various scientific roles in early drug discovery group at Eisai Inc. and in clinical biomarker group at Alexion Pharma. He spent his early career in academic research at Abramson Cancer Center at UPenn.\nHe holds a Bachelor of Technology from Amity University\, a Master of Biotechnology from the University of Pennsylvania\, and an MBA from Sauder School of Business in University of British Columbia.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-panel-discussion-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Slide2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T120000
DTEND;TZID=America/Vancouver:20211118T130000
DTSTAMP:20260407T113801
CREATED:20211111T005628Z
LAST-MODIFIED:20211111T005628Z
UID:28080-1637236800-1637240400@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Panel Discussion
DESCRIPTION:Have you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? This panel discussion event will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. Our speakers will discuss how investment banks identify promising scientific advances\, evaluate strategies\, and harness the power of capital to bring ideas to life. We will hear from life sciences graduates who have successfully made a transition into the world of investment banking and are now changing the face of biotech business in Canada. \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nObjectives \nIntroduce students and early career professionals to the roles investment banks and venture capital firms play for the biotechnology industry\nIdentify key qualifications for candidates interested in transitioning into the investment banking and venture capital industry careers\nProvide information on how a scientific project is evaluated based on the investment banking criteria \nSpeaker Information \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead.\nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University.\nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park. \nBharat Srinivasa\, PhD\nPrincipal\nAmplitude Ventures \nBharat Srinivasa is a co-founder and principal at Amplitude where he is involved in all aspects of deal flow including proving leadership in sourcing\, diligence\, and negotiation. Prior to Amplitude\, he was on the investment team at the BDC Healthcare Fund\, where he was involved in taking multiple companies public. Prior to his VC career\, Bharat was a consultant in forecasting and valuation practice at Foster Rosenblatt\, an international life science consulting firm for biotech and pharma companies where he was responsible for providing business intelligence and commercial analytics and pricing & market access analysis. Bharat has a PhD in Experimental Medicine and Masters of Science in Microbiology and Immunology from McGill University. \nSuman Rao\, PhD\nAssociate\nLumira Ventures \nSuman comes from a strong life science background\, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate and focuses on conducting scientific and technical diligence of investment opportunities. She remains extremely passionate about understanding drivers of complex diseases and through her work at Lumira Ventures\, hopes to bring novel therapies to patients by promoting cutting-edge technologies and medicines.\nPrior to joining Lumira Ventures\, Suman worked in healthcare consulting at L.E.K. Consulting in Boston as a Life Sciences Specialist. During her time at L.E.K.\, she provided strategic advice on growth opportunities\, pipeline expansion\, potential M&A partnerships and financial modeling. Before joining L.E.K.\, Suman spent 4 years doing a Postdoctoral Fellowship at Harvard Medical School and Dana Farber Cancer Institute. During this time\, she worked with a multidisciplinary team to develop therapies to treat advanced cancers. \nParas Sharma\, MSc\nAssociate\nGenesys Capital \nParas came to the Genesys team from adMare Bioinnovations\, where he was responsible for proactive identification of new opportunities\, deal sourcing\, financial valuations and company creation. Prior to his time at adMare\, he served as a Management Consultant providing primary strategic insights to big pharma\, and as a Venture Manager at the CDL.\nMr. Sharma has also held various scientific roles in early drug discovery group at Eisai Inc. and in clinical biomarker group at Alexion Pharma. He spent his early career in academic research at Abramson Cancer Center at UPenn.\nHe holds a Bachelor of Technology from Amity University\, a Master of Biotechnology from the University of Pennsylvania\, and an MBA from Sauder School of Business in University of British Columbia.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-panel-discussion-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Slide2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T120000
DTEND;TZID=America/Vancouver:20211118T130000
DTSTAMP:20260407T113801
CREATED:20211111T005628Z
LAST-MODIFIED:20211111T005628Z
UID:31163-1637236800-1637240400@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Panel Discussion
DESCRIPTION:Have you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? This panel discussion event will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. Our speakers will discuss how investment banks identify promising scientific advances\, evaluate strategies\, and harness the power of capital to bring ideas to life. We will hear from life sciences graduates who have successfully made a transition into the world of investment banking and are now changing the face of biotech business in Canada. \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nObjectives \nIntroduce students and early career professionals to the roles investment banks and venture capital firms play for the biotechnology industry\nIdentify key qualifications for candidates interested in transitioning into the investment banking and venture capital industry careers\nProvide information on how a scientific project is evaluated based on the investment banking criteria \nSpeaker Information \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead.\nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University.\nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park. \nBharat Srinivasa\, PhD\nPrincipal\nAmplitude Ventures \nBharat Srinivasa is a co-founder and principal at Amplitude where he is involved in all aspects of deal flow including proving leadership in sourcing\, diligence\, and negotiation. Prior to Amplitude\, he was on the investment team at the BDC Healthcare Fund\, where he was involved in taking multiple companies public. Prior to his VC career\, Bharat was a consultant in forecasting and valuation practice at Foster Rosenblatt\, an international life science consulting firm for biotech and pharma companies where he was responsible for providing business intelligence and commercial analytics and pricing & market access analysis. Bharat has a PhD in Experimental Medicine and Masters of Science in Microbiology and Immunology from McGill University. \nSuman Rao\, PhD\nAssociate\nLumira Ventures \nSuman comes from a strong life science background\, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate and focuses on conducting scientific and technical diligence of investment opportunities. She remains extremely passionate about understanding drivers of complex diseases and through her work at Lumira Ventures\, hopes to bring novel therapies to patients by promoting cutting-edge technologies and medicines.\nPrior to joining Lumira Ventures\, Suman worked in healthcare consulting at L.E.K. Consulting in Boston as a Life Sciences Specialist. During her time at L.E.K.\, she provided strategic advice on growth opportunities\, pipeline expansion\, potential M&A partnerships and financial modeling. Before joining L.E.K.\, Suman spent 4 years doing a Postdoctoral Fellowship at Harvard Medical School and Dana Farber Cancer Institute. During this time\, she worked with a multidisciplinary team to develop therapies to treat advanced cancers. \nParas Sharma\, MSc\nAssociate\nGenesys Capital \nParas came to the Genesys team from adMare Bioinnovations\, where he was responsible for proactive identification of new opportunities\, deal sourcing\, financial valuations and company creation. Prior to his time at adMare\, he served as a Management Consultant providing primary strategic insights to big pharma\, and as a Venture Manager at the CDL.\nMr. Sharma has also held various scientific roles in early drug discovery group at Eisai Inc. and in clinical biomarker group at Alexion Pharma. He spent his early career in academic research at Abramson Cancer Center at UPenn.\nHe holds a Bachelor of Technology from Amity University\, a Master of Biotechnology from the University of Pennsylvania\, and an MBA from Sauder School of Business in University of British Columbia.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-panel-discussion-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Slide2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T120000
DTEND;TZID=America/Vancouver:20211118T130000
DTSTAMP:20260407T113801
CREATED:20211111T005628Z
LAST-MODIFIED:20211111T005628Z
UID:32623-1637236800-1637240400@scienceinvancouver.com
SUMMARY:Investment Banking for Life Sciences - Panel Discussion
DESCRIPTION:Have you ever wondered how biotech startups get their funding or how they identify monetization strategies for their products? This panel discussion event will focus on the role of investment banks and venture capital groups in getting scientific research funded and out in the public. Our speakers will discuss how investment banks identify promising scientific advances\, evaluate strategies\, and harness the power of capital to bring ideas to life. We will hear from life sciences graduates who have successfully made a transition into the world of investment banking and are now changing the face of biotech business in Canada. \nThe Science to Business Network (www.s2bn.org) was founded 10 years ago to break down silos between universities\, industry\, government and the non-profit sector and to foster a culture of collaboration\, partnership and mutual understanding. Importantly\, the S2BN has been focused on building a network of innovative and creative individuals within and around STEM disciplines. Through panel discussions\, workshops\, mentoring programs\, a podcast and other collaborative initiatives\, the S2BN now has 9 chapters across Canada led by more than 70 grassroots volunteers whose activities now reach more than 2500 people a year. \nObjectives \nIntroduce students and early career professionals to the roles investment banks and venture capital firms play for the biotechnology industry\nIdentify key qualifications for candidates interested in transitioning into the investment banking and venture capital industry careers\nProvide information on how a scientific project is evaluated based on the investment banking criteria \nSpeaker Information \nEvelyn Pau\, PhD\nVice President\, Investment Banking and Recruiting Lead\nBloom Burton \nEvelyn Pau\, Vice President\, Investment Banking and Recruiting Lead joined Bloom Burton & Co. as an Analyst in November 2012. At Bloom Burton\, her responsibilities include monetization planning\, strategy consulting\, and scientific\, clinical and medical due diligence for pharmaceutical\, biotechnology\, and healthcare companies. Evelyn also heads Bloom Burton’s recruiting and talent management efforts as the Recruiting Lead.\nPrior to joining Bloom Burton\, Evelyn was a business development analyst at Tornado Medical Systems (now Tornado Spectral Systems) and a research fellow at SECOR Consulting (now KPMG). Evelyn completed her PhD in Immunology at the University of Toronto\, specializing in genetics and autoimmunity\, and her Bachelor of Medical Sciences Honours in Microbiology and Immunology at Western University.\nCurrently\, Evelyn serves on the Board of Directors of the McMaster Innovation Park. \nBharat Srinivasa\, PhD\nPrincipal\nAmplitude Ventures \nBharat Srinivasa is a co-founder and principal at Amplitude where he is involved in all aspects of deal flow including proving leadership in sourcing\, diligence\, and negotiation. Prior to Amplitude\, he was on the investment team at the BDC Healthcare Fund\, where he was involved in taking multiple companies public. Prior to his VC career\, Bharat was a consultant in forecasting and valuation practice at Foster Rosenblatt\, an international life science consulting firm for biotech and pharma companies where he was responsible for providing business intelligence and commercial analytics and pricing & market access analysis. Bharat has a PhD in Experimental Medicine and Masters of Science in Microbiology and Immunology from McGill University. \nSuman Rao\, PhD\nAssociate\nLumira Ventures \nSuman comes from a strong life science background\, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate and focuses on conducting scientific and technical diligence of investment opportunities. She remains extremely passionate about understanding drivers of complex diseases and through her work at Lumira Ventures\, hopes to bring novel therapies to patients by promoting cutting-edge technologies and medicines.\nPrior to joining Lumira Ventures\, Suman worked in healthcare consulting at L.E.K. Consulting in Boston as a Life Sciences Specialist. During her time at L.E.K.\, she provided strategic advice on growth opportunities\, pipeline expansion\, potential M&A partnerships and financial modeling. Before joining L.E.K.\, Suman spent 4 years doing a Postdoctoral Fellowship at Harvard Medical School and Dana Farber Cancer Institute. During this time\, she worked with a multidisciplinary team to develop therapies to treat advanced cancers. \nParas Sharma\, MSc\nAssociate\nGenesys Capital \nParas came to the Genesys team from adMare Bioinnovations\, where he was responsible for proactive identification of new opportunities\, deal sourcing\, financial valuations and company creation. Prior to his time at adMare\, he served as a Management Consultant providing primary strategic insights to big pharma\, and as a Venture Manager at the CDL.\nMr. Sharma has also held various scientific roles in early drug discovery group at Eisai Inc. and in clinical biomarker group at Alexion Pharma. He spent his early career in academic research at Abramson Cancer Center at UPenn.\nHe holds a Bachelor of Technology from Amity University\, a Master of Biotechnology from the University of Pennsylvania\, and an MBA from Sauder School of Business in University of British Columbia.
URL:https://scienceinvancouver.com/event/investment-banking-for-life-sciences-panel-discussion-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Slide2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T143000
DTEND;TZID=America/Vancouver:20211118T153000
DTSTAMP:20260407T113801
CREATED:20211104T180910Z
LAST-MODIFIED:20211108T191253Z
UID:19143-1637245800-1637249400@scienceinvancouver.com
SUMMARY:WorkBC SSWR/Cloverdale Virtual Hiring Event with STEMCELL Technologies
DESCRIPTION:Looking for a rewarding & exciting career? \nJoin us on Nov 18th with STEMCELL Technologies\, to explore their job opportunities and exciting career paths\, which include competitive benefits and opportunities to achieve your full potential with growth-driven training and development. \nSTEMCELL is a global biotechnology company that develops\, manufactures and sells products and provides services that support academic and industrial scientists. \n  \nWhen: Thursday\, November 18 | 2:30pm to 3:30pm \nWhere: Online through Zoom – Link will be provided upon registration \n  \nFind your next opportunity with STEMCELL Technologies: \n\nCustomer Service Associate\nManufacturing Technician\, Finished Goods\nTechnician\, Assembly and Labeling\nShipper\nMaterial Handler\nBusiness Development Officer\n\n\nManufacturing Technologist\, Clean Room\nQuality Assurance Associate\, Product Release\nResearch Associate\nExecutive Assistant\n\nMore jobs on their career page: \nhttps://jobs.stemcell.com/search-jobs
URL:https://scienceinvancouver.com/event/workbc-sswr-cloverdale-virtual-hiring-event-with-stemcell-technologies/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/workbc-stemcell-virtual-hiring-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T143000
DTEND;TZID=America/Vancouver:20211118T153000
DTSTAMP:20260407T113802
CREATED:20211104T180910Z
LAST-MODIFIED:20211104T180910Z
UID:26459-1637245800-1637249400@scienceinvancouver.com
SUMMARY:WorkBC SSWR/Cloverdale Virtual Hiring Event with STEMCELL Technologies
DESCRIPTION:Looking for a rewarding & exciting career? \nJoin us on Nov 18th with STEMCELL Technologies\, to explore their job opportunities and exciting career paths\, which include competitive benefits and opportunities to achieve your full potential with growth-driven training and development. \nSTEMCELL is a global biotechnology company that develops\, manufactures and sells products and provides services that support academic and industrial scientists. \n  \nWhen: Thursday\, November 18 | 2:30pm to 3:30pm \nWhere: Online through Zoom – Link will be provided upon registration \n  \nFind your next opportunity with STEMCELL Technologies: \n\nCustomer Service Associate\nManufacturing Technician\, Finished Goods\nTechnician\, Assembly and Labeling\nShipper\nMaterial Handler\nBusiness Development Officer\n\n\nManufacturing Technologist\, Clean Room\nQuality Assurance Associate\, Product Release\nResearch Associate\nExecutive Assistant\n\nMore jobs on their career page: \nhttps://jobs.stemcell.com/search-jobs
URL:https://scienceinvancouver.com/event/workbc-sswr-cloverdale-virtual-hiring-event-with-stemcell-technologies-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/workbc-stemcell-virtual-hiring-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T143000
DTEND;TZID=America/Vancouver:20211118T153000
DTSTAMP:20260407T113802
CREATED:20211104T180910Z
LAST-MODIFIED:20211104T180910Z
UID:28074-1637245800-1637249400@scienceinvancouver.com
SUMMARY:WorkBC SSWR/Cloverdale Virtual Hiring Event with STEMCELL Technologies
DESCRIPTION:Looking for a rewarding & exciting career? \nJoin us on Nov 18th with STEMCELL Technologies\, to explore their job opportunities and exciting career paths\, which include competitive benefits and opportunities to achieve your full potential with growth-driven training and development. \nSTEMCELL is a global biotechnology company that develops\, manufactures and sells products and provides services that support academic and industrial scientists. \n  \nWhen: Thursday\, November 18 | 2:30pm to 3:30pm \nWhere: Online through Zoom – Link will be provided upon registration \n  \nFind your next opportunity with STEMCELL Technologies: \n\nCustomer Service Associate\nManufacturing Technician\, Finished Goods\nTechnician\, Assembly and Labeling\nShipper\nMaterial Handler\nBusiness Development Officer\n\n\nManufacturing Technologist\, Clean Room\nQuality Assurance Associate\, Product Release\nResearch Associate\nExecutive Assistant\n\nMore jobs on their career page: \nhttps://jobs.stemcell.com/search-jobs
URL:https://scienceinvancouver.com/event/workbc-sswr-cloverdale-virtual-hiring-event-with-stemcell-technologies-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/workbc-stemcell-virtual-hiring-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T143000
DTEND;TZID=America/Vancouver:20211118T153000
DTSTAMP:20260407T113802
CREATED:20211104T180910Z
LAST-MODIFIED:20211104T180910Z
UID:31157-1637245800-1637249400@scienceinvancouver.com
SUMMARY:WorkBC SSWR/Cloverdale Virtual Hiring Event with STEMCELL Technologies
DESCRIPTION:Looking for a rewarding & exciting career? \nJoin us on Nov 18th with STEMCELL Technologies\, to explore their job opportunities and exciting career paths\, which include competitive benefits and opportunities to achieve your full potential with growth-driven training and development. \nSTEMCELL is a global biotechnology company that develops\, manufactures and sells products and provides services that support academic and industrial scientists. \n  \nWhen: Thursday\, November 18 | 2:30pm to 3:30pm \nWhere: Online through Zoom – Link will be provided upon registration \n  \nFind your next opportunity with STEMCELL Technologies: \n\nCustomer Service Associate\nManufacturing Technician\, Finished Goods\nTechnician\, Assembly and Labeling\nShipper\nMaterial Handler\nBusiness Development Officer\n\n\nManufacturing Technologist\, Clean Room\nQuality Assurance Associate\, Product Release\nResearch Associate\nExecutive Assistant\n\nMore jobs on their career page: \nhttps://jobs.stemcell.com/search-jobs
URL:https://scienceinvancouver.com/event/workbc-sswr-cloverdale-virtual-hiring-event-with-stemcell-technologies-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/workbc-stemcell-virtual-hiring-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T143000
DTEND;TZID=America/Vancouver:20211118T153000
DTSTAMP:20260407T113802
CREATED:20211104T180910Z
LAST-MODIFIED:20211104T180910Z
UID:32617-1637245800-1637249400@scienceinvancouver.com
SUMMARY:WorkBC SSWR/Cloverdale Virtual Hiring Event with STEMCELL Technologies
DESCRIPTION:Looking for a rewarding & exciting career? \nJoin us on Nov 18th with STEMCELL Technologies\, to explore their job opportunities and exciting career paths\, which include competitive benefits and opportunities to achieve your full potential with growth-driven training and development. \nSTEMCELL is a global biotechnology company that develops\, manufactures and sells products and provides services that support academic and industrial scientists. \n  \nWhen: Thursday\, November 18 | 2:30pm to 3:30pm \nWhere: Online through Zoom – Link will be provided upon registration \n  \nFind your next opportunity with STEMCELL Technologies: \n\nCustomer Service Associate\nManufacturing Technician\, Finished Goods\nTechnician\, Assembly and Labeling\nShipper\nMaterial Handler\nBusiness Development Officer\n\n\nManufacturing Technologist\, Clean Room\nQuality Assurance Associate\, Product Release\nResearch Associate\nExecutive Assistant\n\nMore jobs on their career page: \nhttps://jobs.stemcell.com/search-jobs
URL:https://scienceinvancouver.com/event/workbc-sswr-cloverdale-virtual-hiring-event-with-stemcell-technologies-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/workbc-stemcell-virtual-hiring-event.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T190000
DTEND;TZID=America/Vancouver:20211118T210000
DTSTAMP:20260407T113802
CREATED:20211021T215702Z
LAST-MODIFIED:20211021T215702Z
UID:18908-1637262000-1637269200@scienceinvancouver.com
SUMMARY:An Evening of Inspiration
DESCRIPTION:Delve into some of the best and brightest minds at BC Cancer in a unique\, interactive virtual experience … An Evening of Inspiration\, presented by BMO. \nFriends of the BC Cancer Foundation from across the province are invited to connect with world-renowned BC Cancer scientists in an immersive\, ‘as close to in-person as it gets’ event using the hybrid digital platform EventHive VX. The evening will focus on innovations within our cancer community and offer attendees an opportunity to learn about and support advancements in life-saving prostate cancer technology. \nHighlights of the evening \nBC Cancer radiation oncologist Dr. Abraham Alexander will shine a light on Prostate Specific Membrane Antigen (PSMA)-PET\, a state-of-the-art imaging technology\, and the profound impact it’s having on managing – and curing – prostate cancer. Improving access to these game-changing scans will save lives across B.C.\, and provide hope to the over 3\,500 individuals a year who receive a prostate cancer diagnosis in our province. \nArt and science collide to create beautiful possibilities that “combine analytical clarity with artistic dimension” in a special multimedia exhibit by Dr. Martin Krzywinski\, scientist (and resident artist) at Canada’s Michael Smith Genome Sciences Centre. Dr. Krzywinski’s artful information graphics have appeared in the New York Times and Wired\, on book covers and in scientific journals. \nIntimate breakout round-table virtual groups\, hosted by BC Cancer experts\, promise to inspire lively conversations about donor impact\, research projects and programs of interest. And behind the scenes\, guests can bid on extraordinary experiences and prize packages during the evening’s blind auction. \nJoin us for this invaluable opportunity to connect with BC Cancer excellence in An Evening of Inspiration\, presented by BMO on November 18 at 7 p.m. \nAttendance to this event is by a suggested tax-receiptable donation of $1\,000 – and we thank you in advance for any additional donation amount in support of the 1 in 9 individuals who will receive a prostate cancer diagnosis in their lifetime.
URL:https://scienceinvancouver.com/event/an-evening-of-inspiration/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T190000
DTEND;TZID=America/Vancouver:20211118T210000
DTSTAMP:20260407T113802
CREATED:20211021T215702Z
LAST-MODIFIED:20211021T215702Z
UID:26453-1637262000-1637269200@scienceinvancouver.com
SUMMARY:An Evening of Inspiration
DESCRIPTION:Delve into some of the best and brightest minds at BC Cancer in a unique\, interactive virtual experience … An Evening of Inspiration\, presented by BMO. \nFriends of the BC Cancer Foundation from across the province are invited to connect with world-renowned BC Cancer scientists in an immersive\, ‘as close to in-person as it gets’ event using the hybrid digital platform EventHive VX. The evening will focus on innovations within our cancer community and offer attendees an opportunity to learn about and support advancements in life-saving prostate cancer technology. \nHighlights of the evening \nBC Cancer radiation oncologist Dr. Abraham Alexander will shine a light on Prostate Specific Membrane Antigen (PSMA)-PET\, a state-of-the-art imaging technology\, and the profound impact it’s having on managing – and curing – prostate cancer. Improving access to these game-changing scans will save lives across B.C.\, and provide hope to the over 3\,500 individuals a year who receive a prostate cancer diagnosis in our province. \nArt and science collide to create beautiful possibilities that “combine analytical clarity with artistic dimension” in a special multimedia exhibit by Dr. Martin Krzywinski\, scientist (and resident artist) at Canada’s Michael Smith Genome Sciences Centre. Dr. Krzywinski’s artful information graphics have appeared in the New York Times and Wired\, on book covers and in scientific journals. \nIntimate breakout round-table virtual groups\, hosted by BC Cancer experts\, promise to inspire lively conversations about donor impact\, research projects and programs of interest. And behind the scenes\, guests can bid on extraordinary experiences and prize packages during the evening’s blind auction. \nJoin us for this invaluable opportunity to connect with BC Cancer excellence in An Evening of Inspiration\, presented by BMO on November 18 at 7 p.m. \nAttendance to this event is by a suggested tax-receiptable donation of $1\,000 – and we thank you in advance for any additional donation amount in support of the 1 in 9 individuals who will receive a prostate cancer diagnosis in their lifetime.
URL:https://scienceinvancouver.com/event/an-evening-of-inspiration-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T190000
DTEND;TZID=America/Vancouver:20211118T210000
DTSTAMP:20260407T113802
CREATED:20211021T215702Z
LAST-MODIFIED:20211021T215702Z
UID:28068-1637262000-1637269200@scienceinvancouver.com
SUMMARY:An Evening of Inspiration
DESCRIPTION:Delve into some of the best and brightest minds at BC Cancer in a unique\, interactive virtual experience … An Evening of Inspiration\, presented by BMO. \nFriends of the BC Cancer Foundation from across the province are invited to connect with world-renowned BC Cancer scientists in an immersive\, ‘as close to in-person as it gets’ event using the hybrid digital platform EventHive VX. The evening will focus on innovations within our cancer community and offer attendees an opportunity to learn about and support advancements in life-saving prostate cancer technology. \nHighlights of the evening \nBC Cancer radiation oncologist Dr. Abraham Alexander will shine a light on Prostate Specific Membrane Antigen (PSMA)-PET\, a state-of-the-art imaging technology\, and the profound impact it’s having on managing – and curing – prostate cancer. Improving access to these game-changing scans will save lives across B.C.\, and provide hope to the over 3\,500 individuals a year who receive a prostate cancer diagnosis in our province. \nArt and science collide to create beautiful possibilities that “combine analytical clarity with artistic dimension” in a special multimedia exhibit by Dr. Martin Krzywinski\, scientist (and resident artist) at Canada’s Michael Smith Genome Sciences Centre. Dr. Krzywinski’s artful information graphics have appeared in the New York Times and Wired\, on book covers and in scientific journals. \nIntimate breakout round-table virtual groups\, hosted by BC Cancer experts\, promise to inspire lively conversations about donor impact\, research projects and programs of interest. And behind the scenes\, guests can bid on extraordinary experiences and prize packages during the evening’s blind auction. \nJoin us for this invaluable opportunity to connect with BC Cancer excellence in An Evening of Inspiration\, presented by BMO on November 18 at 7 p.m. \nAttendance to this event is by a suggested tax-receiptable donation of $1\,000 – and we thank you in advance for any additional donation amount in support of the 1 in 9 individuals who will receive a prostate cancer diagnosis in their lifetime.
URL:https://scienceinvancouver.com/event/an-evening-of-inspiration-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T190000
DTEND;TZID=America/Vancouver:20211118T210000
DTSTAMP:20260407T113802
CREATED:20211021T215702Z
LAST-MODIFIED:20211021T215702Z
UID:31151-1637262000-1637269200@scienceinvancouver.com
SUMMARY:An Evening of Inspiration
DESCRIPTION:Delve into some of the best and brightest minds at BC Cancer in a unique\, interactive virtual experience … An Evening of Inspiration\, presented by BMO. \nFriends of the BC Cancer Foundation from across the province are invited to connect with world-renowned BC Cancer scientists in an immersive\, ‘as close to in-person as it gets’ event using the hybrid digital platform EventHive VX. The evening will focus on innovations within our cancer community and offer attendees an opportunity to learn about and support advancements in life-saving prostate cancer technology. \nHighlights of the evening \nBC Cancer radiation oncologist Dr. Abraham Alexander will shine a light on Prostate Specific Membrane Antigen (PSMA)-PET\, a state-of-the-art imaging technology\, and the profound impact it’s having on managing – and curing – prostate cancer. Improving access to these game-changing scans will save lives across B.C.\, and provide hope to the over 3\,500 individuals a year who receive a prostate cancer diagnosis in our province. \nArt and science collide to create beautiful possibilities that “combine analytical clarity with artistic dimension” in a special multimedia exhibit by Dr. Martin Krzywinski\, scientist (and resident artist) at Canada’s Michael Smith Genome Sciences Centre. Dr. Krzywinski’s artful information graphics have appeared in the New York Times and Wired\, on book covers and in scientific journals. \nIntimate breakout round-table virtual groups\, hosted by BC Cancer experts\, promise to inspire lively conversations about donor impact\, research projects and programs of interest. And behind the scenes\, guests can bid on extraordinary experiences and prize packages during the evening’s blind auction. \nJoin us for this invaluable opportunity to connect with BC Cancer excellence in An Evening of Inspiration\, presented by BMO on November 18 at 7 p.m. \nAttendance to this event is by a suggested tax-receiptable donation of $1\,000 – and we thank you in advance for any additional donation amount in support of the 1 in 9 individuals who will receive a prostate cancer diagnosis in their lifetime.
URL:https://scienceinvancouver.com/event/an-evening-of-inspiration-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211118T190000
DTEND;TZID=America/Vancouver:20211118T210000
DTSTAMP:20260407T113802
CREATED:20211021T215702Z
LAST-MODIFIED:20211021T215702Z
UID:32611-1637262000-1637269200@scienceinvancouver.com
SUMMARY:An Evening of Inspiration
DESCRIPTION:Delve into some of the best and brightest minds at BC Cancer in a unique\, interactive virtual experience … An Evening of Inspiration\, presented by BMO. \nFriends of the BC Cancer Foundation from across the province are invited to connect with world-renowned BC Cancer scientists in an immersive\, ‘as close to in-person as it gets’ event using the hybrid digital platform EventHive VX. The evening will focus on innovations within our cancer community and offer attendees an opportunity to learn about and support advancements in life-saving prostate cancer technology. \nHighlights of the evening \nBC Cancer radiation oncologist Dr. Abraham Alexander will shine a light on Prostate Specific Membrane Antigen (PSMA)-PET\, a state-of-the-art imaging technology\, and the profound impact it’s having on managing – and curing – prostate cancer. Improving access to these game-changing scans will save lives across B.C.\, and provide hope to the over 3\,500 individuals a year who receive a prostate cancer diagnosis in our province. \nArt and science collide to create beautiful possibilities that “combine analytical clarity with artistic dimension” in a special multimedia exhibit by Dr. Martin Krzywinski\, scientist (and resident artist) at Canada’s Michael Smith Genome Sciences Centre. Dr. Krzywinski’s artful information graphics have appeared in the New York Times and Wired\, on book covers and in scientific journals. \nIntimate breakout round-table virtual groups\, hosted by BC Cancer experts\, promise to inspire lively conversations about donor impact\, research projects and programs of interest. And behind the scenes\, guests can bid on extraordinary experiences and prize packages during the evening’s blind auction. \nJoin us for this invaluable opportunity to connect with BC Cancer excellence in An Evening of Inspiration\, presented by BMO on November 18 at 7 p.m. \nAttendance to this event is by a suggested tax-receiptable donation of $1\,000 – and we thank you in advance for any additional donation amount in support of the 1 in 9 individuals who will receive a prostate cancer diagnosis in their lifetime.
URL:https://scienceinvancouver.com/event/an-evening-of-inspiration-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T110000
DTEND;TZID=America/Vancouver:20211119T120000
DTSTAMP:20260407T113802
CREATED:20211013T171410Z
LAST-MODIFIED:20211013T171410Z
UID:18759-1637319600-1637323200@scienceinvancouver.com
SUMMARY:The 16th Harold Copp Lecture
DESCRIPTION:Vishva M. Dixit\, MD\, PhD\nGenentech\, Inc.\, San Francisco\nVice President of Early Discovery Research\nMember\, National Academy of Sciences\nForeign Member of the Royal Society (ForMemRS)\nMember\, National Academy of Medicine\nFellow\, American Academy of Arts and Sciences\nForeign Member of the Royal Netherlands Academy of Arts and Sciences\nForeign Member\, European Molecular Biology Organization \nZoom Registration Link: https://ubc.zoom.us/meeting/register/u5Eqcu2orjouEtXjYCnPN5i4i2cGtmHpH7u8 \nWhy so many ways to die? The non-canonical inflammasome pathway\nProper coordination of cellular metabolism and its integration with immune response is paramount to function of cells\, organs\, and organisms. The endoplasmic reticulum (ER) is the main site for protein and lipid synthesis\, trafficking\, and the storage of cellular calcium. Work in our group over the past two decades demonstrated that ER also plays a significant role in adaptation to metabolic fluctuations\, adaptation to metabolic challenges\, and their integration to immune response. This important “integrated metabolic response” is disrupted by metabolic stress of chronic metabolic diseases such as obesity and diabetes in animal models and humans. Restoration of the ER adaptive folding responses by genetic or chemical means improve metabolic homeostasis in preclinical models and humans. Therefore\, understanding the compositional\, structural\, and functional regulation of the ER and the mechanisms giving rise to its dysfunction remain critical areas of investigation and carry important translational opportunities. In recent studies\, we have discovered alteration in structural organization and architecture of the organelle and identified adaptive responses that emanate from the ER during metabolic stress in physiological or pathological contexts. Here\, I will present emerging evidence integrating metaflammation to endoplasmic reticulum and mitochondria function and regulation of interactions between organelles during metabolic fluctuations. I will also present our most recent observations on a novel pathway mediated by the NRF family of ER bound transcription factors\, which orchestrates previously unknown countermeasures against metabolic stress to preserve ER integrity and metabolic health. Finally\, how these molecular mechanisms may be exploited to understand chronic inflammatory diseases and leveraged to design novel and effective preventive and therapeutic strategies will be discussed. \nContact Information: Dr. Ivan Robert Nabi\n604-822-7000 ivan.robert.nabi@ubc.ca
URL:https://scienceinvancouver.com/event/the-16th-harold-copp-lecture/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T110000
DTEND;TZID=America/Vancouver:20211119T120000
DTSTAMP:20260407T113802
CREATED:20211013T171410Z
LAST-MODIFIED:20211013T171410Z
UID:26446-1637319600-1637323200@scienceinvancouver.com
SUMMARY:The 16th Harold Copp Lecture
DESCRIPTION:Vishva M. Dixit\, MD\, PhD\nGenentech\, Inc.\, San Francisco\nVice President of Early Discovery Research\nMember\, National Academy of Sciences\nForeign Member of the Royal Society (ForMemRS)\nMember\, National Academy of Medicine\nFellow\, American Academy of Arts and Sciences\nForeign Member of the Royal Netherlands Academy of Arts and Sciences\nForeign Member\, European Molecular Biology Organization \nZoom Registration Link: https://ubc.zoom.us/meeting/register/u5Eqcu2orjouEtXjYCnPN5i4i2cGtmHpH7u8 \nWhy so many ways to die? The non-canonical inflammasome pathway\nProper coordination of cellular metabolism and its integration with immune response is paramount to function of cells\, organs\, and organisms. The endoplasmic reticulum (ER) is the main site for protein and lipid synthesis\, trafficking\, and the storage of cellular calcium. Work in our group over the past two decades demonstrated that ER also plays a significant role in adaptation to metabolic fluctuations\, adaptation to metabolic challenges\, and their integration to immune response. This important “integrated metabolic response” is disrupted by metabolic stress of chronic metabolic diseases such as obesity and diabetes in animal models and humans. Restoration of the ER adaptive folding responses by genetic or chemical means improve metabolic homeostasis in preclinical models and humans. Therefore\, understanding the compositional\, structural\, and functional regulation of the ER and the mechanisms giving rise to its dysfunction remain critical areas of investigation and carry important translational opportunities. In recent studies\, we have discovered alteration in structural organization and architecture of the organelle and identified adaptive responses that emanate from the ER during metabolic stress in physiological or pathological contexts. Here\, I will present emerging evidence integrating metaflammation to endoplasmic reticulum and mitochondria function and regulation of interactions between organelles during metabolic fluctuations. I will also present our most recent observations on a novel pathway mediated by the NRF family of ER bound transcription factors\, which orchestrates previously unknown countermeasures against metabolic stress to preserve ER integrity and metabolic health. Finally\, how these molecular mechanisms may be exploited to understand chronic inflammatory diseases and leveraged to design novel and effective preventive and therapeutic strategies will be discussed. \nContact Information: Dr. Ivan Robert Nabi\n604-822-7000 ivan.robert.nabi@ubc.ca
URL:https://scienceinvancouver.com/event/the-16th-harold-copp-lecture-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T110000
DTEND;TZID=America/Vancouver:20211119T120000
DTSTAMP:20260407T113802
CREATED:20211013T171410Z
LAST-MODIFIED:20211013T171410Z
UID:28061-1637319600-1637323200@scienceinvancouver.com
SUMMARY:The 16th Harold Copp Lecture
DESCRIPTION:Vishva M. Dixit\, MD\, PhD\nGenentech\, Inc.\, San Francisco\nVice President of Early Discovery Research\nMember\, National Academy of Sciences\nForeign Member of the Royal Society (ForMemRS)\nMember\, National Academy of Medicine\nFellow\, American Academy of Arts and Sciences\nForeign Member of the Royal Netherlands Academy of Arts and Sciences\nForeign Member\, European Molecular Biology Organization \nZoom Registration Link: https://ubc.zoom.us/meeting/register/u5Eqcu2orjouEtXjYCnPN5i4i2cGtmHpH7u8 \nWhy so many ways to die? The non-canonical inflammasome pathway\nProper coordination of cellular metabolism and its integration with immune response is paramount to function of cells\, organs\, and organisms. The endoplasmic reticulum (ER) is the main site for protein and lipid synthesis\, trafficking\, and the storage of cellular calcium. Work in our group over the past two decades demonstrated that ER also plays a significant role in adaptation to metabolic fluctuations\, adaptation to metabolic challenges\, and their integration to immune response. This important “integrated metabolic response” is disrupted by metabolic stress of chronic metabolic diseases such as obesity and diabetes in animal models and humans. Restoration of the ER adaptive folding responses by genetic or chemical means improve metabolic homeostasis in preclinical models and humans. Therefore\, understanding the compositional\, structural\, and functional regulation of the ER and the mechanisms giving rise to its dysfunction remain critical areas of investigation and carry important translational opportunities. In recent studies\, we have discovered alteration in structural organization and architecture of the organelle and identified adaptive responses that emanate from the ER during metabolic stress in physiological or pathological contexts. Here\, I will present emerging evidence integrating metaflammation to endoplasmic reticulum and mitochondria function and regulation of interactions between organelles during metabolic fluctuations. I will also present our most recent observations on a novel pathway mediated by the NRF family of ER bound transcription factors\, which orchestrates previously unknown countermeasures against metabolic stress to preserve ER integrity and metabolic health. Finally\, how these molecular mechanisms may be exploited to understand chronic inflammatory diseases and leveraged to design novel and effective preventive and therapeutic strategies will be discussed. \nContact Information: Dr. Ivan Robert Nabi\n604-822-7000 ivan.robert.nabi@ubc.ca
URL:https://scienceinvancouver.com/event/the-16th-harold-copp-lecture-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T110000
DTEND;TZID=America/Vancouver:20211119T120000
DTSTAMP:20260407T113802
CREATED:20211013T171410Z
LAST-MODIFIED:20211013T171410Z
UID:31144-1637319600-1637323200@scienceinvancouver.com
SUMMARY:The 16th Harold Copp Lecture
DESCRIPTION:Vishva M. Dixit\, MD\, PhD\nGenentech\, Inc.\, San Francisco\nVice President of Early Discovery Research\nMember\, National Academy of Sciences\nForeign Member of the Royal Society (ForMemRS)\nMember\, National Academy of Medicine\nFellow\, American Academy of Arts and Sciences\nForeign Member of the Royal Netherlands Academy of Arts and Sciences\nForeign Member\, European Molecular Biology Organization \nZoom Registration Link: https://ubc.zoom.us/meeting/register/u5Eqcu2orjouEtXjYCnPN5i4i2cGtmHpH7u8 \nWhy so many ways to die? The non-canonical inflammasome pathway\nProper coordination of cellular metabolism and its integration with immune response is paramount to function of cells\, organs\, and organisms. The endoplasmic reticulum (ER) is the main site for protein and lipid synthesis\, trafficking\, and the storage of cellular calcium. Work in our group over the past two decades demonstrated that ER also plays a significant role in adaptation to metabolic fluctuations\, adaptation to metabolic challenges\, and their integration to immune response. This important “integrated metabolic response” is disrupted by metabolic stress of chronic metabolic diseases such as obesity and diabetes in animal models and humans. Restoration of the ER adaptive folding responses by genetic or chemical means improve metabolic homeostasis in preclinical models and humans. Therefore\, understanding the compositional\, structural\, and functional regulation of the ER and the mechanisms giving rise to its dysfunction remain critical areas of investigation and carry important translational opportunities. In recent studies\, we have discovered alteration in structural organization and architecture of the organelle and identified adaptive responses that emanate from the ER during metabolic stress in physiological or pathological contexts. Here\, I will present emerging evidence integrating metaflammation to endoplasmic reticulum and mitochondria function and regulation of interactions between organelles during metabolic fluctuations. I will also present our most recent observations on a novel pathway mediated by the NRF family of ER bound transcription factors\, which orchestrates previously unknown countermeasures against metabolic stress to preserve ER integrity and metabolic health. Finally\, how these molecular mechanisms may be exploited to understand chronic inflammatory diseases and leveraged to design novel and effective preventive and therapeutic strategies will be discussed. \nContact Information: Dr. Ivan Robert Nabi\n604-822-7000 ivan.robert.nabi@ubc.ca
URL:https://scienceinvancouver.com/event/the-16th-harold-copp-lecture-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T110000
DTEND;TZID=America/Vancouver:20211119T120000
DTSTAMP:20260407T113802
CREATED:20211013T171410Z
LAST-MODIFIED:20211013T171410Z
UID:32604-1637319600-1637323200@scienceinvancouver.com
SUMMARY:The 16th Harold Copp Lecture
DESCRIPTION:Vishva M. Dixit\, MD\, PhD\nGenentech\, Inc.\, San Francisco\nVice President of Early Discovery Research\nMember\, National Academy of Sciences\nForeign Member of the Royal Society (ForMemRS)\nMember\, National Academy of Medicine\nFellow\, American Academy of Arts and Sciences\nForeign Member of the Royal Netherlands Academy of Arts and Sciences\nForeign Member\, European Molecular Biology Organization \nZoom Registration Link: https://ubc.zoom.us/meeting/register/u5Eqcu2orjouEtXjYCnPN5i4i2cGtmHpH7u8 \nWhy so many ways to die? The non-canonical inflammasome pathway\nProper coordination of cellular metabolism and its integration with immune response is paramount to function of cells\, organs\, and organisms. The endoplasmic reticulum (ER) is the main site for protein and lipid synthesis\, trafficking\, and the storage of cellular calcium. Work in our group over the past two decades demonstrated that ER also plays a significant role in adaptation to metabolic fluctuations\, adaptation to metabolic challenges\, and their integration to immune response. This important “integrated metabolic response” is disrupted by metabolic stress of chronic metabolic diseases such as obesity and diabetes in animal models and humans. Restoration of the ER adaptive folding responses by genetic or chemical means improve metabolic homeostasis in preclinical models and humans. Therefore\, understanding the compositional\, structural\, and functional regulation of the ER and the mechanisms giving rise to its dysfunction remain critical areas of investigation and carry important translational opportunities. In recent studies\, we have discovered alteration in structural organization and architecture of the organelle and identified adaptive responses that emanate from the ER during metabolic stress in physiological or pathological contexts. Here\, I will present emerging evidence integrating metaflammation to endoplasmic reticulum and mitochondria function and regulation of interactions between organelles during metabolic fluctuations. I will also present our most recent observations on a novel pathway mediated by the NRF family of ER bound transcription factors\, which orchestrates previously unknown countermeasures against metabolic stress to preserve ER integrity and metabolic health. Finally\, how these molecular mechanisms may be exploited to understand chronic inflammatory diseases and leveraged to design novel and effective preventive and therapeutic strategies will be discussed. \nContact Information: Dr. Ivan Robert Nabi\n604-822-7000 ivan.robert.nabi@ubc.ca
URL:https://scienceinvancouver.com/event/the-16th-harold-copp-lecture-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T120000
DTEND;TZID=America/Vancouver:20211119T130000
DTSTAMP:20260407T113802
CREATED:20211108T185308Z
LAST-MODIFIED:20211108T185308Z
UID:19252-1637323200-1637326800@scienceinvancouver.com
SUMMARY:BioInnovation Scientist (BIS) Program for Young Scientists
DESCRIPTION:The adMare Academy offers a free online asynchronous program called the BioInnovation Scientist (BIS) Program for bench scientists looking to transition their careers to drug development & drug commercialization. \nThe BIS program was designed to complement students’ academic education and employer talent development programs. It is the only program that focuses on delivering the skills needed to innovate in laboratories.
URL:https://scienceinvancouver.com/event/bioinnovation-scientist-bis-program-for-young-scientists/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/admare-bioinnovation-scientist-program.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T120000
DTEND;TZID=America/Vancouver:20211119T130000
DTSTAMP:20260407T113802
CREATED:20211108T185308Z
LAST-MODIFIED:20211108T185308Z
UID:26463-1637323200-1637326800@scienceinvancouver.com
SUMMARY:BioInnovation Scientist (BIS) Program for Young Scientists
DESCRIPTION:The adMare Academy offers a free online asynchronous program called the BioInnovation Scientist (BIS) Program for bench scientists looking to transition their careers to drug development & drug commercialization. \nThe BIS program was designed to complement students’ academic education and employer talent development programs. It is the only program that focuses on delivering the skills needed to innovate in laboratories.
URL:https://scienceinvancouver.com/event/bioinnovation-scientist-bis-program-for-young-scientists-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/admare-bioinnovation-scientist-program.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T120000
DTEND;TZID=America/Vancouver:20211119T130000
DTSTAMP:20260407T113802
CREATED:20211108T185308Z
LAST-MODIFIED:20211108T185308Z
UID:28078-1637323200-1637326800@scienceinvancouver.com
SUMMARY:BioInnovation Scientist (BIS) Program for Young Scientists
DESCRIPTION:The adMare Academy offers a free online asynchronous program called the BioInnovation Scientist (BIS) Program for bench scientists looking to transition their careers to drug development & drug commercialization. \nThe BIS program was designed to complement students’ academic education and employer talent development programs. It is the only program that focuses on delivering the skills needed to innovate in laboratories.
URL:https://scienceinvancouver.com/event/bioinnovation-scientist-bis-program-for-young-scientists-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/admare-bioinnovation-scientist-program.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T120000
DTEND;TZID=America/Vancouver:20211119T130000
DTSTAMP:20260407T113802
CREATED:20211108T185308Z
LAST-MODIFIED:20211108T185308Z
UID:31161-1637323200-1637326800@scienceinvancouver.com
SUMMARY:BioInnovation Scientist (BIS) Program for Young Scientists
DESCRIPTION:The adMare Academy offers a free online asynchronous program called the BioInnovation Scientist (BIS) Program for bench scientists looking to transition their careers to drug development & drug commercialization. \nThe BIS program was designed to complement students’ academic education and employer talent development programs. It is the only program that focuses on delivering the skills needed to innovate in laboratories.
URL:https://scienceinvancouver.com/event/bioinnovation-scientist-bis-program-for-young-scientists-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/admare-bioinnovation-scientist-program.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211119T120000
DTEND;TZID=America/Vancouver:20211119T130000
DTSTAMP:20260407T113802
CREATED:20211108T185308Z
LAST-MODIFIED:20211108T185308Z
UID:32621-1637323200-1637326800@scienceinvancouver.com
SUMMARY:BioInnovation Scientist (BIS) Program for Young Scientists
DESCRIPTION:The adMare Academy offers a free online asynchronous program called the BioInnovation Scientist (BIS) Program for bench scientists looking to transition their careers to drug development & drug commercialization. \nThe BIS program was designed to complement students’ academic education and employer talent development programs. It is the only program that focuses on delivering the skills needed to innovate in laboratories.
URL:https://scienceinvancouver.com/event/bioinnovation-scientist-bis-program-for-young-scientists-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/admare-bioinnovation-scientist-program.png
END:VEVENT
END:VCALENDAR